Rosuvastatin Effect on Atherosclerotic Plaque Metabolism - a Subclinical Atherosclerosis Imaging Study With 18F-NaF PET-CT
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 24 May 2018
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Cardiovascular disorders
- Focus Therapeutic Use
- Acronyms ROPPET-NAF
- 31 Aug 2018 Biomarkers information updated
- 09 May 2018 Planned End Date changed from 1 Sep 2018 to 1 Sep 2020.
- 09 May 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Apr 2020.